A Summary of the 2020 Gastric Cancer Summit at Stanford University.
About this Publication
Title
A Summary of the 2020 Gastric Cancer Summit at Stanford University.
Pubmed ID
32707045
(View this publication on the PubMed website)
Digital Object Identifier
Publication
Gastroenterology. 2020 Oct; Volume 159 (Issue 4): Pages 1221-1226
Authors
Huang RJ, Koh H, Hwang JH, Summit Leaders
Affiliations
- Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford, California.
- The Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
- Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford, California. Electronic address: jooha@stanford.edu.
Abstract
There exists no coherent national strategy for the early detection or prevention of gastric cancer in the United States (US), even among identified high-risk groups such as Asian Americans, African Americans, Hispanic Americans, and Alaska Native/American Indian peoples. As a result, patients with gastric cancer in the US are diagnosed at later stages and demonstrate worse overall survival compared to nations of East Asia with established screening programs (Table 1). The under-recognition of gastric cancer risk within minority communities is a significant unaddressed healthcare disparity.
Related CDAS Studies
Related CDAS Projects
- 2013-0192: Helicobacter pylori and colorectal cancer risk (Meira Epplein - 2013)